1.
2.
Pediatr Dermatol
; 41(3): 458-460, 2024.
Article
in English
| MEDLINE
| ID: mdl-38305078
ABSTRACT
Mast cells (MCs) can release a variety of biologically active mediators under different circumstances, such as fever or vaccination. Our aim was to evaluate the incidence and severity of MC activation symptoms induced by SARS-CoV-2 virus (COVID-19) infection and vaccination in a cohort of 92 pediatric patients with cutaneous mastocytosis. Our findings support previous evidence on the safety of COVID-19 infection and vaccination in patients with MC disorders.
Subject(s)
COVID-19 Vaccines , COVID-19 , Mastocytosis, Cutaneous , SARS-CoV-2 , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Cross-Sectional Studies , Retrospective Studies , Vaccination
3.
Clin Exp Dermatol
; 48(8): 940-941, 2023 07 21.
Article
in English
| MEDLINE
| ID: mdl-37098182
Subject(s)
Biosimilar Pharmaceuticals , Hidradenitis Suppurativa , Mevalonate Kinase Deficiency , Psoriasis , Humans , Adalimumab/adverse effects , Ustekinumab/adverse effects , Hidradenitis Suppurativa/complications , Hidradenitis Suppurativa/drug therapy , Hidradenitis Suppurativa/chemically induced , Biosimilar Pharmaceuticals/adverse effects , Psoriasis/complications , Psoriasis/drug therapy , Psoriasis/chemically induced
4.
Clin Exp Dermatol
; 48(5): 535-536, 2023 04 27.
Article
in English
| MEDLINE
| ID: mdl-36763700
5.
Photodermatol Photoimmunol Photomed
; 39(3): 294-295, 2023 05.
Article
in English
| MEDLINE
| ID: mdl-35996345
